|
|
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab *Among work published between January 1, 2023 and December 31, 2023.
|
|
|
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab *Among work published between January 1, 2023 and December 31, 2023.
|